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To the Editor,
Obesity is a multifactorial disorder caused by a combi-
nation of environmental, behavioral and genetic factors 
[1]. The most common forms of obesity are the polygenic 
ones (up to 95% of all cases), where each susceptibility 
gene marginally contributes on the weight increase [2]. 
By contrast, monogenic obesity is rarely observed, and 
causative mutations have been described in a few genes, 
i.e. melanocortin 4 receptor (MC4R), proopiomelanocor-
tin (POMC), uncoupling protein 3 (UCP3), prohormone 
convertase 1 (PC1), leptin (LEP) and leptin receptor (LEPR) 
genes [3]. In other cases with a documented genetic cause, 
obesity is usually associated to other clinical features and 
is only one of the aspects of more complex syndromes [4].
In addition to the investigation of mutations/poly-
morphisms in single genes associated to obesity, com-
parative genomic hybridization (CGH) array technology 
allows the rapid identification of genomic imbalances in 
the entire genome supporting the possible role of genomic 
gains and/or losses in the etiology of a number of genetic 
disorders [5] and behavioral abnormalities [6]. At present, 
thanks to the great analytical power of CGH array to detect 
ever small chromosomal rearrangements, a large number 
of copy number variants (CNV) have been discovered both 
in apparently healthy control individuals and in obese 
patients [7]. We describe the genetic characterization of 
five related individuals (two males, one female and their 
parents) from a family with a high prevalence of obesity, 
living in Southern Italy for at least three generations. We 
screened the presence of genomic alteration by CGH array 
(as described in Supplemental material, References 1S, 
2S). All patients gave their written informed consent to the 
study, which was performed according to the Declaration 
of Helsinki II and was approved by the Ethics Committee of 
our Faculty of Medicine (authorization no. 193/06, October 
25, 2006; amendment no. 193/06/ESES1, October 1, 2014).
The male II.3 (Figure 1) came to our attention 
at 10  years for his morbid obesity (body mass index 
[BMI] = 49 kg/m2), type 2 diabetes, hypertension and 
dyslipidemia. Clinical and biochemical characteristics 
of the patient are reported in Supplemental Table 1. 
Behavioral examination evidenced a “snacker” pheno-
type, whereas no mental retardation or any other intel-
lectual disabilities were reported. CGH array analysis 
showed the presence of a 3q29 microduplication of 1.59 
Mbp (chr3:195,747,856-197,339,329) (Figure 2A and B). 
Clinical follow-up highlighted that the patient under-
went a first endoscopic intragastric balloon (IGB) place-
ment in 2013, then removed 6 months later, and a second 
IGB placement in 2015, also removed after 6  months, 
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Figure 2: Molecular details of 3q29 duplication.
Array-CGH profile of chromosome 3 showing (A) a terminal microduplication of 1.59 Mb at 3q29 indicated by an elliptical red circle, and (B) 






















Figure 1: Pedigree of the studied family members.
The clinical features detected in each family member together to 
BMI are also indicated. Mother (I.1), Father (I.2), Son 1 (II.1), Son 2 
(Daughter, II.2), Son 3 (II.3). D, diabetes; H, dypertension; Dy, dys-
lipidemia; y, age in years; BMI, body mass index (kg/m2).
both procedures with no significant (~10 kg) weight 
loss, current BMI being equal to 47.7 kg/m2. In 2016, he 
underwent a melanoma excision surgery on the right leg 
( Supplemental Table 2).
Clinical, biochemical and genetic characterization 
was then extended to other members of the family. The 
obtained results are the following:
 – I.1: The mother (44  years) was overweight at admis-
sion (BMI = 29 kg/m2), with normal blood pressure and 
normal glycemic and lipidemic profiles. 3q29 micro-
duplication was observed by CGH array. Clinical fol-
low-up showed no variation up to 2017.
 – I.2: The father (47 years) presented at admission mild 
obesity (BMI = 39 kg/m2), type 2 diabetes, dyslipidemia 
and hypertension. The clinical follow-up highlighted 
that the patient underwent a sleeve gastrectomy sur-
gery in March 2015 with a subsequent weight loss of 
~33 kg (current BMI = 33.9 kg/m2).
Brought to you by | Universita degli Studi di Napoli
Authenticated
Download Date | 3/5/18 2:14 PM
Vitale et al.: 3q29 microduplication in a small family with complex metabolic phenotype from Southern Italy      3
 – II.1: The first male son (25  years) showed at admis-
sion severe obesity (BMI = 48 kg/m2), dyslipidemia 
and type 2 diabetes. The presence of the maternally 
inherited 3q29  microduplication resulted at CGH 
array analysis. The clinical follow-up showed that the 
patient lost ~30 kg after dietary intervention (current 
BMI = 36.2 kg/m2).
 – II.2: The daughter (22  years) at admission was over-
weight (BMI = 28 kg/m2), with normal blood pres-
sure and normal glycemic and lipidemic profiles. 
No variation was present at CGH array analysis. The 
clinical follow-up highlighted that the patient had a 
pregnancy during which she developed gestational 
diabetes. After pregnancy, she lost ~30 kg by dietary 
intervention (current BMI = 28 kg/m2).
The presence of a 1.59-Mbp microduplication in the 3q29 
region resulted by CGH array was observed in three family 
members (I.1, II.1 and II.3). The genomic view reporting the 
UCSC genes (GRCh37/hg19) is shown in Figure 2, panel C. 
The altered region includes several disease-related (OMIM) 
genes listed as follows: TFRC (OMIM*190010), ZDHHC19, 
OSTalpha (OMIM*612084), PCYT1A (OMIM*123695), 
TCTEX1D2, TM4SF19, UBXN7 (OMIM*616379), RNF168 
(OMIM*612688), C3orf43, WDR53 (OMIM*615110), 
FBXO45 (OMIM*609112), LRRC33 (OMIM*615322), 
C3orf34 (OMIM*615586), PIGX (OMIM*610276), PAK2 
(OMIM*605022), SENP5 (OMIM*612845), NCBP2 
(OMIM*605133), LOC152217, PIGZ (OMIM*611671), 
MFI2 (OMIM*155750), DLG1 (OMIM*601014) and BDH1 
(OMIM*603063). The duplication of this region was con-
firmed by RTqPCR analysis: the tested genes were ~1.5 
times more abundant in subjects bearing the 3q29 micro-
duplication compared to control subjects (mean RQ 
obtained in the three patients bearing the CNV: TFRC = 1.55, 
PAK2 = 1.63, BDH1 = 1.60). The 3q29  microduplication was 
neither observed in confirmation cohort of 100 unrelated 
morbid obese patients previously screened by our group 
for the presence of alterations in obesity-related genes (i.e. 
POMC, MC4R, MC3R, FTO, UCP1, UCP3) [8, 9] (mean RQs: 
TFRC = 1.03, PAK2 = 1.00, BDH1 = 0.97) nor in 100 normal 
weight control subjects analyzed by CGH array.
Twenty genes were included in this duplicated region. 
Among these genes, TFRC, OSTalpha, PCYT1A, TCTEX1D2, 
PAK2 and C3orf34 were previously associated to the obese 
phenotype, some of them contributing to the impaired 
insulin sensitivity and body fat accumulation (Supple-
mental Material, References 3S-11S).
In summary, most of the members of this family 
showed common features, including overweight or 
obesity, diabetes and hypertension. The clinical features 
of these patients suggested a familial form of obesity 
together with obesity-associated disorders. In addition, 
the male second-generation patients (II.1 and II.3) har-
bored the maternally inherited 1.59-Mbp microduplica-
tion in 3q29.
The clinical features of patients bearing such micro-
duplication are extremely heterogeneous, including 
mild to moderate intellectual disability (90%–100%), 
obesity (60%), speech delay (50%), delayed walking 
(50%), autistic features (25%) and ataxic gait (25%–
30%) [10].
The absence of any intellectual disability or speech 
delay in our index case and his relatives should be 
explained by the reduced penetrance of the 3q29 microdu-
plication already reported; in fact, other patients bearing 
the same genomic alteration with no mental retardation 
have been described [11].
Finally, the 3q29 region was also found to have sig-
nificant evidence of linkage to melanoma susceptibil-
ity in 42 Swedish families at-risk for melanoma [12]; in 
agreement, the subject II.3 in this family and his mater-
nal aunt (reported data) were affected by cutaneous 
melanoma.
Based on these literature data, we could hypothe-
size that a duplication of the genes encompassed by the 
3q29  microduplication could concur in both the altered 
insulin sensitivity and obese phenotype that we observed 
in the second-generation male patients; in this family, the 
absence of the phenotype related to cognitive and intellec-
tual abilities highlights variable expressivity and reduced 
penetrance.
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